Literature DB >> 35507183

Assessment of Breast Cancer Stem Cell Activity Using a Spheroid Formation Assay.

Ajeya Nandi1, Rumela Chakrabarti2.   

Abstract

Evidence is emerging that cancer cells are arranged as a hierarchy that spans from stem cells to lineage-restricted progenitor cells. The recent development of spheroid cultures with several tissue type has provided new opportunities to assess cancer stem cell (CSC) activity by allowing them to propagate under conditions that resemble the microenvironment for growth of tumors. One tissue type widely used for stem cell investigations is mammary tissue, and the sphere formation assay has been used in both normal mammary tissue and in breast cancer. Here, we describe detailed experimental methodology for generating and propagating spheres from normal mammary tissue and primary breast tumors of mice, patient derived xenografts (PDXs) and breast cancer cell lines. We further describe how these sphere cultures can be employed for coculture assays to assess the effect of tumor microenvironment (TME) on self-renewal ability of CSCs in breast cancer.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Cancer stem cells; Matrigel; Patient derived xenografts; Spheroid formation assay; Tumorsphere

Mesh:

Year:  2022        PMID: 35507183     DOI: 10.1007/978-1-0716-1979-7_33

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor.

Authors:  L M Shaw; C Chao; U M Wewer; A M Mercurio
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

  1 in total
  1 in total

1.  Capric Acid Behaves Agonistic Effect on Calcitriol to Control Inflammatory Mediators in Colon Cancer Cells.

Authors:  Amr Negm; Azza Sedky; Hany Elsawy
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.